Jan. 28, 2014—The Vanderbilt Diabetes Center, the Vanderbilt Diabetes Research and Training Center (DRTC) and the Vanderbilt Center for Diabetes Translation Research (CDTR) announce the availability of pilot and feasibility grants in the following areas: Translational or behavioral science research (Type II translational research) related to diabetes or obesity. This grant mechanism is open to junior faculty...
Jan. 13, 2014—Vanderbilt researchers describe a new technique for identifying factors that stimulate the proliferation of pancreatic beta cells – factors that might offer therapeutic options for diabetes.
Dec. 23, 2013—This year’s most popular research stories plumbed mysteries of the brain, examined complex social phenomena, shed light on dark matter, uncovered a surprising link between our three greatest health threats and more.
Oct. 24, 2013—The IDIOM study is designed to compare how a diet with moderate caloric restriction, alone or with long-acting insulin, affects areas of the brain’s dopamine system that are involved in food intake, reward and the sense of pleasure people get from eating.
Oct. 16, 2013—The hormone relaxin may offer a novel approach for treating diet-induced insulin resistance.
Oct. 2, 2013—A pair of Vanderbilt graduate students has received a national award of $15,000 to pursue the development of an unique synthetic foam as a new treatment for deep skin wounds such as chronic foot ulcers caused by diabetes.
Sep. 17, 2013—Researchers at the Vanderbilt Heart and Vascular Institute and Massachusetts General Hospital have identified a biomarker that can predict diabetes risk up to 10 years before onset of the disease.
Sep. 12, 2013—Vanderbilt’s Eskind Diabetes Clinic has been selected to examine the ability of the drug abatacept to prevent type 1 diabetes (T1D). As part of the TrialNet consortium, Vanderbilt will be one of 14 North American sites observing the effects of the drug in people at high risk to develop T1D.
Aug. 9, 2013—Gaining and losing weight during “yo-yo dieting” may contribute to an exaggerated immune response in fat tissue that increases metabolic dysfunction more than steady weight gain alone.
Aug. 8, 2013—Last week, 130 students from more than 75 medical schools across the nation were at Vanderbilt to take part in the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Medical Student Research Symposium, sponsored by the National Institutes of Health and organized by the Vanderbilt Diabetes Center.
Jul. 11, 2013—Following her successful heart valve surgery at Vanderbilt, Gwendolyn English and her family faced a long journey home to Florida. Her family was concerned about the trip, because English has diabetes and her blood sugar levels had been fluctuating erratically.
Jun. 6, 2013—A component of the extracellular matrix that surrounds cells plays a role in insulin resistance and may be a good therapeutic target.